Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2556 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Crucell signs licensing agreement with Centocor

Star technology is a production technology that is particularly useful for the production of recombinant human antibodies and proteins. It has a potentially broad application and is reported

PerkinElmer introduces new screening system

According to the company, Operetta employs its proprietary new Harmony software which provides researchers with easy-to-use building blocks for creating user configurable workflows via simple step-by-step procedures. An

FDA to review Lilly and Daiichi’s anticlotting drug

Prasugrel is an investigational antiplatelet agent for the treatment of patients with acute coronary syndromes who are being managed with an artery-opening procedure known as percutaneous coronary intervention,

Impax sued over copy of infection drug Doryx

Impax Laboratories, a technology based specialty pharmaceutical company, applies its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the

Power Medical Interventions names new CFO

Mr Posner’s career spans over 20 years in global finance positions in the healthcare industry. Most recently, Mr Posner served as executive vice president, and CFO with Pharmacopeia.

Quidel’s CEO to retire

Mark Pulido, chairman of the board of Quidel, said: “I speak for the full board of directors of Quidel in recognizing Caren Mason for the outstanding leadership and

Xoma names new CFO

In this position, Mr Kurland will be responsible for directing Xoma’s financial strategy, accounting, financial planning and investor relations functions. Prior to joining Xoma, Mr Kurland served as